Year: 2020
Type: article
Study design: Observational Study
Abstract: PURPOSE: Germline pathogenic variants in the exonuclease domain (ED) of polymerases POLE and POLD1 predispose to adenomatous polyps, colorectal cancer (CRC), endometrial tumors, and other malignancies, and exhibit increased mutation rate and highly specific associated mutational signatures. The tumor spectrum and prevalence of POLE and POLD1 variants in hereditary cancer are evaluated in this study. METHODS: POLE and POLD1 were sequenced in 2813 unrelated probands referred for genetic counseling (2309 hereditary cancer patients subjected to a multigene panel, and 504 patients selected based on phenotypic characteristics). Cosegregation and case-control studies, yeast-based functional assays, and tumor mutational analyses were performed for variant interpretation. RESULTS: Twelve ED missense variants, 6 loss-of-function, and 23 outside-ED predicted-deleterious missense variants, all with population allele frequencies <1%, were identified. One ED variant (POLE p.Met294Arg) was classified as likely pathogenic, four as likely benign, and seven as variants of unknown significance. The most commonly associated tumor types were colorectal, endometrial and ovarian cancers. Loss-of-function and outside-ED variants are likely not pathogenic for this syndrome. CONCLUSIONS: Polymerase proofreading-associated syndrome constitutes 0.1-0.4% of familial cancer cases, reaching 0.3-0.7% when only CRC and polyposis are considered. ED variant interpretation is challenging and should include multiple pieces of evidence.
Source: Genetics in Medicine
Authors: Pilar Mur, Sandra García-Mulero, Jesús del Valle, Lorena Magraner-Pardo, August Vidal, Marta Pineda, Giacomo Cinnirella, Edgar Martín-Ramos, Tirso Pons, Adriana López-Doriga, Sami Belhadj, Lidia Feliubadaló, Pau M. Munoz-Torres, Matilde Navarro, Elia Grau, Esther Darder, Gemma Llort, Judit Sanz, Teresa Ramón y Cajal, Judith Balmana, Joan Brunet, Victor Moreno, Josep M. Piulats, Xavier Matías-Guiu, Rebeca Sanz-Pamplona, Rosa Aligué, Gabriel Capellá, Conxi Lázaro, Laura Valle
Institutions: Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Centro de Investigación Biomédica en Red de Cáncer, Spanish National Cancer Research Centre, Bellvitge University Hospital, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Consejo Superior de Investigaciones Científicas, Centro Nacional de Biotecnología, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Consorci Sanitari de Terrassa, Corporació Sanitària Parc Taulí, Althaia, Hospital de Sant Pau, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,900
Funders: Ministerio de Ciencia, Innovación y Universidades, Centres de Recerca de Catalunya, Fundación Olga Torres, Generalitat de Catalunya, Ministerio de Ciencia e Innovación, Centro de Investigación Biomédica en Red de Cáncer, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III
Awards: G1571755681, Abordaje de los retos actuales en el diagnóstico genético del cáncer hereditario mediante análisis integrativo de datos moleculares, clínicos y poblacionales, G2028348840, G20582625, G3523929155, Identificación de marcadores de susceptibilidad genética útiles para el diseño de estrategias personalizadas de cribado, G4540457744, G4662712581, G5101934552, G525796669, G6771536215, Descifrando la complejidad genética del cáncer hereditario mediante un análisis multidimensional de un panel de genes de diseño propio, G7897750139, G8104449165, G822659861, G8360268252, G8507014214
OpenAlex ID: W3049583106
